Markets:

Overview

News

Currencies

International

Treasuries

Rapid Micro Biosystems, Inc. - Class A Common Stock (NQ:RPID)

2.490 -0.190 (-7.09%)

Streaming Delayed Price Updated: 3:01 PM EDT, Mar 19, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Rapid Micro Biosystems, Inc. - Class A Common Stock

< Previous 1 2 3 Next >

Rapid Micro (RPID) Earnings Call Transcript ↗

March 12, 2026

Rapid Micro (RPID) Earnings Call Transcript

Via The Motley Fool

Topics Earnings

Discover the top movers in Thursday's pre-market session. ↗

March 12, 2026

Via Chartmill

Rapid Micro Biosystems Inc (NASDAQ:RPID) Reports Record Q4 Revenue but Misses Estimates, Shares Drop 9% ↗

March 12, 2026

Via Chartmill

These stocks are moving in today's after hours session ↗

January 13, 2026

Via Chartmill

Earnings Outlook For Rapid Micro Biosystems ↗

November 06, 2025

Via Benzinga

A Look Ahead: Rapid Micro Biosystems's Earnings Forecast ↗

August 11, 2025

Via Benzinga

Rapid Micro Biosystems's Earnings Outlook ↗

May 08, 2025

Via Benzinga

Rapid Micro Biosystems Inc-A (NASDAQ:RPID) Posts Mixed Q3 2025 Results, Raises Full-Year Guidance ↗

November 07, 2025

Rapid Micro Biosystems posts mixed Q3 2025 results, missing estimates but raising full-year guidance after securing a major new customer order.

Via Chartmill

Earnings Scheduled For November 7, 2025 ↗

November 07, 2025

Via Benzinga

Rapid Micro Biosystems: Q4 Earnings Insights ↗

March 01, 2024

Via Benzinga

Rapid Micro Biosystems Earnings Preview ↗

February 29, 2024

Via Benzinga

Rapid Micro Biosystems's Earnings Outlook ↗

November 02, 2023

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

September 22, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

August 12, 2025

Via Benzinga

Earnings Scheduled For May 9, 2025 ↗

May 09, 2025

Via Benzinga

Earnings Scheduled For August 12, 2025 ↗

August 12, 2025

Via Benzinga

US Stocks Likely To Open Higher Following A Sell-Off, 'This Choppy Start To 2025 Isn't Abnormal. Don't Panic,' Says Expert Highlighting Seasonal Weakness In The First Quarter After Elections ↗

February 28, 2025

U.S. stock futures rose on Friday following Thursday's sell-off. Futures advanced except the small-cap gauge Russell 2000.

Via Benzinga

Earnings Scheduled For February 28, 2025 ↗

February 28, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

January 21, 2025

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

January 15, 2025

Via Benzinga

RPID Stock Earnings: Rapid Micro Biosystems Misses EPS, Beats Revenue for Q1 2024 ↗

May 03, 2024

RPID stock results show that Rapid Micro Biosystems missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.

Via InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

May 03, 2024

Pre-market stock movers are worth checking out this morning as we dive into all of the biggest news moving shares on Friday!

Via InvestorPlace

Why Apple Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket ↗

May 03, 2024

Via Benzinga

Earnings Scheduled For March 1, 2024 ↗

March 01, 2024

Companies Reporting Before The Bell • McEwen Mining (NYSE:MUX) is estimated to report quarterly loss at $0.28 per share on revenue of $71.72 million.

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

January 11, 2024

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

January 04, 2024

Via Benzinga

Top 5 Health Care Stocks That Could Lead To Your Biggest Gains in January ↗

January 02, 2024

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

Via Benzinga

Earnings Scheduled For November 3, 2023 ↗

November 03, 2023

Companies Reporting Before The Bell • Arcutis Biotherapeutics (NASDAQ:ARQT) is expected to report quarterly loss at $0.86 per share on revenue of $32.83 million.

Via Benzinga

Cardio Diagnostics And 2 Other Penny Stocks Insiders Are Buying ↗

September 11, 2023

The Dow Jones closed higher by around 75 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...

Via Benzinga

Topics Stocks

Around $15M Bet On Taysha Gene Therapies? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying ↗

August 17, 2023

The Dow Jones closed lower by around 180 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...

Via Benzinga

Topics Stocks

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.